Journey Medical Corp (DERM) Stock Analysis

Journey Medical Corp (DERM) is a publicly traded company in the HEALTHCARE sector. It trades at $6.02, carries a market capitalization of $168.65M. This page summarizes the public market data, fundamentals, and frequently asked questions for DERM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $6.02
• Market Cap: $168.65M
• EPS: $-0.37
• 52-Week High: $9.55
• 52-Week Low: $4.31

Market Sentiment

Journey Medical Corp currently has a Neutral sentiment score of 0.04.

About Journey Medical Corp

Journey Medical Corp is a biopharmaceutical company focused on developing and commercializing innovative therapies for dermatological conditions, addressing significant unmet medical needs. The company boasts a strong pipeline of specialized products aimed at enhancing patient outcomes, supported by strategic partnerships and clinical advancements. With its commitment to innovation and expertise in the field, Journey Medical is well-positioned to capitalize on growth opportunities within the ...

GNG Research Analysis

GNG Research scores Journey Medical Corp (DERM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DERM.

Frequently Asked Questions

Does DERM pay dividends?

Journey Medical Corp (DERM) does not currently pay a regular dividend.

What is DERM's market cap?

Journey Medical Corp (DERM) has a market capitalization of $168.65M with a current stock price of $6.02.